• Skip to primary navigation
  • Skip to main content
  • Skip to footer
ElevateBio

ElevateBio

Powering the creation of cell & gene therapies at a speed the world deserves.

  • Investors & Media
    • Investors & Media Overview
    • Press Releases
    • Posters & Publications
    • Elevated Insights
  • Careers
  • Locations
  • Contact
  • Search
  • Manufacturing & Development Services
    • End-to-End Capabilities Overview
    • cGMP Manufacturing and Automation
    • Process Development
    • Analytical Development
    • Next-Generation Sequencing
    • Quality
    • Regulatory CMC
    • ElevateBio BaseCamp Certifications and Compliance
    • Modalities Powered by ElevateBio
  • Gene Editing Technologies and R&D
    • Technology Platforms Overview
    • Technology Platform
    • Therapeutic Applications
    • AI & Protein Engineering
  • Genetic Medicines
  • Partnering
  • About
    • About Overview
    • How We Work
    • Our Team
    • Culture of Expedition
    • Careers
  • Investors & Media
    • Investors & Media Overview
    • Press Releases
    • Posters & Publications
    • Elevated Insights
  • Careers
  • Locations
  • Contact
  • Manufacturing & Development Services basecamp

    Basecamp
    Manufacturing & Development Services Overview

    Capabilities & Services
    • cGMP Manufacturing and Automation
    • Process Development
    • Analytical Development
    • Next-Generation Sequencing
    Expertise
    • Quality
    • Regulatory CMC
    • BaseCamp Certifications and Compliance
    • Modalities Powered by ElevateBio
  • Gene Editing Technologies and R&D life edit

    Life Edit
    Gene Editing Technologies and R&D Overview

    • Technology Platform
    • Therapeutic Applications
    • AI & Protein Engineering
  • Genetic Medicines
  • Partnering
  • About
    • About Overview
    • How We Work
    • Our Team
    • Culture of Expedition
    • Careers

Co-founders

March 4, 2023 by

David Hallal is a 30-year veteran in the biopharmaceutical industry with expertise in early-stage company building as well as operating large multinational biotech companies. He is a co-founder of ElevateBio, previously served as Chairman and CEO, and now serves as Executive Chairman on its Board of Directors. He is currently CEO of Scholar Rock.

March 4, 2023 by

Dr. Mitchell Finer is a co-founder of ElevateBio and previously served as the Company’s President of Research & Development and as Chief Executive Officer of Life Edit Therapeutics, ElevateBio’s gene editing business. Additionally, Dr. Finer is an executive partner at MPM Capital.

March 4, 2023 by

Vikas Sinha brings more than 30 years of experience in executive finance roles in the life sciences industry. He is a co-founder of ElevateBio, previously served as CFO, and now serves as on its Board of Directors and is Chair of the Audit Comittee. He is Chief Financial Officer of Scholar Rock.

Footer

ElevateBio

Investors & Media

LinkedIn Twitter

© 2025 ElevateBio. All Rights Reserved.

Privacy & Cookie Policy

  • Manufacturing & Development Services basecamp
  • Gene Editing Technologies and R&D life edit
  • Genetic Medicines
  • Partnering
  • About
  • Posters & Publications
  • Elevated Insights
  • Careers
  • Locations
  • Contact
MENU
  • Manufacturing & Development Services
    • End-to-End Capabilities Overview
    • cGMP Manufacturing and Automation
    • Process Development
    • Analytical Development
    • Next-Generation Sequencing
    • Quality
    • Regulatory CMC
    • ElevateBio BaseCamp Certifications and Compliance
    • Modalities Powered by ElevateBio
  • Gene Editing Technologies and R&D
    • Technology Platforms Overview
    • Technology Platform
    • Therapeutic Applications
    • AI & Protein Engineering
  • Genetic Medicines
  • Partnering
  • About
    • About Overview
    • How We Work
    • Our Team
    • Culture of Expedition
    • Careers
  • Investors & Media
    • Investors & Media Overview
    • Press Releases
    • Posters & Publications
    • Elevated Insights
  • Careers
  • Locations
  • Contact